S_HHS_2023A 04/19/2023 11:07:48 AM Committee Summary

Senator Fields, prime bill sponsor, presented House Bill 23-1026 concerning allowing courts to appoint a legal representative to represent the child’s best interest in child custody cases or in cases that concern the allocation of parental responsibilities. The bill also requires courts to presume parental determinations regarding grandparent time are in the best interest of the child, but allows grandparents the opportunity to provide evidence to overcome this presumption. The bill also changes the term “visitation” to “family time.”

Committee members provided closing remarks.

Senator Bridges and
Senator Danielson, co-prime bill sponsors, presented Senate Bill 23-284
concerning requiring state-regulated insurance plans to cover a 12-month
supply of all FDA-approved contraceptives, or their therapeutic equivalent,
when permitted by the prescription and supply, without imposing prior authorization
requirements. The bill specifies that dispensing fees must be paid per
unit. Additionally, the plan must include point-of-sale coverage for over-the-counter
contraceptives without requiring a prescription, prior authorization, or
step therapy. The Commissioner of Insurance must establish corresponding
reporting requirements.



Committee members
asked the bill sponsors questions.

Jason Hopfer, representing
the Colorado Association of Health Plans, testified to amend the bill.



Alejandra Beatty,
representing themself, testified in support of the bill.



Ms Kayla Frawley,
representing ProgressNow Colorado, testified in support of the bill.

The committee recessed.

Mrs. Claudia Perez,
representing Planned Parenthood of the Rocky Mountains Action Fund, testified
in support of the bill.



Mar Galvez, representing
the Organization for Latina Opportunity and Reproductive Rights, testified
in support of the bill.



Ms. Kathia Garcia,
representing themself, testified in support of the bill.



Ms. Trina Griego,
representing themself, testified in support of the bill.



Alicia Perez,
representing themself, testified in support of the bill.



Committee members
asked the panel questions.

Jill Mullen, representing
the Division of Insurance, testified in support of the bill.



Committee members
asked the panel questions.

The committee recessed.

The committee resumed.

Senator Jaquez Lewis
and Senator Buckner presented House Bill 23-1225 which makes several changes
to the Colorado Prescription Drug Affordability Review Board (the board)
in the Division of Insurance in the Department of Regulatory Agencies (DORA).
These changes include:

• limiting conflict
  of interest recusal requirements to board members only (excluding staff
  and contractors);
• changing various
  cost thresholds for different types of drugs that prompt the board to conduct
  a review;
• requiring the
  board to produce a report summarizing drug affordability data that it uses;removing
  the cap on the number of prescription drugs for which an upper payment
  limits may be established by the board annually;
• making minor changes
  to the board’s appeal process;
• extending the
  repeal date and associated sunset review of the board from September 1,
  2026, to September 1, 2031; and
• expanding when
  an individual may request a review to include cases when the drug is no
  longer available in the state.

Hope Stonner, representing
the Colorado Consumer Health Initiative, testified in support of the bill.



Austin Blumenfeld,
representing Centennial State Prosperity, testified in support of the bill.



Ms. Bethany Pray,
representing the Colorado Center on Law and Policy, testified in support
of the bill.

Mrs. Ethnie Treick,
representing themself, testified in support of the bill.



Dr. Jennifer Kordell,
representing the Colorado Academy of Family Physicians, testified in support
of the bill.



Dr. Natalia Tucker,
representing the Colorado Academy of Family Physicians, testified in support
of the bill.



Committee members
asked the panel questions.

Ms. Dana Malick,
representing PhRMA, testified in opposition to the bill.



Ms. Amy Goodman,
representing the Colorado BioScience Association, testified in opposition
to the bill.



Mrs. Nina Anderson,
representing themself, testified in opposition to the bill.



Committee members
asked the panel questions.

Brett Michelin, representing
AAM, testified to amend the bill.



Brian Warren,
representing the Biotechnology Innovation Organization, testified in opposition
to the bill.



Rachel Beck, representing
the Colorado Competitive Council, testified in opposition to the bill.

Commissioner Michael
Conway, representing the Colorado Division of Insurance, testified in support
of the bill.



Ms. Lila Cummings,
representing the State of Colorado, testified in support of the bill.



Committee members
asked the panel questions.

Stacy Suniga, representing
themself, testified in support of the bill.



Additional written
testimony can be found in Attachment B.

Senator Jaquez Lewis
explained amendment L.019 (Attachment C).



Committee members
provided comments on the amendments and asked the bill sponsors questions.

Committee members provided additional comments.

Senator Smallwood
explained amendment L.015 (Attachment D).



Committee members
discussed the amendment.

The committee resumed.

Committee members continued to discuss amendment L.015.

The bill sponsors provided closing remarks.